STAT3 and ovarian carcinoma: There was no significant difference in STAT3/p-STAT3 expression between endometrioid and nonendometrioid ovarian carcinoma patients (OR = 0.97, 95% CI = 0.67–1.39, p = 0.853) (Fig. 10).